- The FDA is offering $1 million in grant funding for mining electronic health record data for the purpose of postmarket drug-safety surveillance.
- The agency's Center for Drug Evaluation and Research will award the one-year grant to a bidder that can develop "new analytic methodologies" that will help identify pharmaceutical-related safety issues in the FDA's Mini-Sentinel Distributed Database. The database is a pilot program with access to 178 million medical records.
- A single recipient will be announced by July 15. Applications are due June 15.
The holy grail here is safety surveillance in real time—the kind of analytics that could have caught the recent CRE outbreaks tied to duodenoscopes, including one at a Seattle hospital that caused 35 patients to fall ill and 11 to die over a muti-year period.
The recipient will support the Innovations in Medical Evidence Development and Surveillance-Methods program, which according to the grant announcement, "aims to improve the tools for conducting post-marketing safety surveillance using automated healthcare data and to foster their adoption."